|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size 10/23/15 Procter & Gamble Co 10-Q 9/30/15 74:6.9M |
Document/Exhibit Description Pages Size
1: 10-Q Quarterly Report HTML 440K
2: EX-3.2 Exhibit 3.2 Regulations as Approved by the Board HTML 77K
of Directors on June 9, 2015
3: EX-10.1 Exhibit 10.1 Summary of the Company's Short Term HTML 42K
Achievement Reward Program
4: EX-10.2 Exhibit 10.2 Short Term Achievement Reward Program HTML 176K
5: EX-10.3 Exhibit 10.3 Summary of the Company's Performance HTML 42K
Stock Program
6: EX-10.4 Exhibit 10.4 Performance Stock Program HTML 61K
7: EX-10.5 Exhibit 10.5 Summary of the Company's Key Manager HTML 37K
Long-Term Incentive Program
8: EX-10.6 Exhibit 10.6 Key Manager Long-Term Incentive HTML 247K
Program
9: EX-10.7 Exhibit 10.7 Summary of the Company's Retirement HTML 31K
Plan Restoration Program
10: EX-10.8 Exhibit 10.8 Retirement Plan Restoration Program HTML 64K
11: EX-10.9 Exhibit 10.9 the Procter & Gamble 2014 Stock and HTML 54K
Incentive Compensation Plan
12: EX-12 Exhibit 12 Computation of Ratio of Earnings to HTML 41K
Fixed Charges
13: EX-31.1 Exhibit 31.1 Rule 13A-14(A)/15D-14(A) HTML 31K
Certification Chief Executive Officer
14: EX-31.2 Exhibit 31.2 Rule 13A-14(A)/15D-14(A) HTML 31K
Certification Chief Financial Officer
15: EX-32.1 Exhibit 32.1 Section 1350 Certifications Chief HTML 26K
Executive Officer
16: EX-32.2 Exhibit 32.2 Section 1350 Certifications Chief HTML 25K
Financial Officer
53: R1 Document and Entity Information HTML 50K
43: R2 Consolidated Statements of Earnings HTML 97K
51: R3 Condolidated Statements of Comprehensive Income HTML 52K
55: R4 Consolidated Balance Sheets HTML 145K
69: R5 Consolidated Statements of Cash Flows HTML 108K
45: R6 Basis of Presentation HTML 29K
50: R7 New Accounting Pronouncements and Policies HTML 30K
40: R8 Segment Information HTML 70K
33: R9 Goodwill and Other Intangible Assets HTML 66K
70: R10 Share-Based Compensation HTML 29K
57: R11 Risk Management Activities and Fair Value HTML 110K
Measurements
56: R12 Accumulated Other Comprehensive Income (Loss) HTML 55K
61: R13 Earnings Per Share HTML 84K
62: R14 Restructuring Program HTML 65K
60: R15 Commitments and Contingencies HTML 31K
63: R16 Discontinued Operations HTML 181K
52: R17 Segment Information (Tables) HTML 65K
54: R18 Goodwill and Other Intangible Assets (Tables) HTML 57K
59: R19 Risk Management Activities and Fair Value HTML 114K
Measurements (Tables)
74: R20 Accumulated Other Comprehensive Income (Loss) HTML 52K
(Tables)
65: R21 Earnings Per Share (Tables) HTML 82K
47: R22 Restructuring Program (Tables) HTML 58K
58: R23 Discontinued Operations (Tables) HTML 169K
49: R24 Segment Information (Details) HTML 48K
28: R25 Goodwill and Other Intangible Assets - Additional HTML 41K
Information (Details)
66: R26 Goodwill and Other Intangible Assets - Change in HTML 44K
the Net Carrying Amount of Goodwill by Global
Business Unit (Details)
71: R27 Goodwill and Other Intangible Assets - HTML 33K
Identifiable Intangible Assets (Details)
36: R28 Share-Based Compensation (Details) HTML 27K
35: R29 Postretirement Benefits (Details) HTML 31K
38: R30 Risk Management Activities and Fair Value HTML 44K
Measurements - Additional Information (Details)
39: R31 Risk Management Activities and Fair Value HTML 32K
Measurements - Assets Measured at Fair Value on A
Recurring Basis (Details)
41: R32 Risk Management Activities and Fair Value HTML 39K
Measurements - Derivative Notional Amounts and
Fair Value (Details)
27: R33 Risk Management Activities and Fair Value HTML 35K
Measurements Risk Management Activities and Fair
Value Measurements - Gain (Loss) on Derivative
Instruments (Effective Portion) (Details)
64: R34 Risk Management Activities and Fair Value HTML 48K
Measurements - Gain (Loss) on Derivative
Instruments (Details)
46: R35 Accumulated Other Comprehensive Income (Loss) HTML 61K
Accumulated Other Comprehensive Income (Loss) -
Changes in Aoci and Reclassification Out of Aoci
(Details)
48: R36 Earnings Per Share (Details) HTML 80K
31: R37 Earnings Per Share - Antidilutive Securities HTML 29K
(Details)
73: R38 Restructuring Program - Additional Information HTML 57K
(Details)
23: R39 Restructuring Program - Restructuring Reserve by HTML 46K
Type of Costs (Details)
42: R40 Restructuring Program - Restructuring Costs Per HTML 42K
Segment (Details)
68: R41 Commitments and Contingencies - Additional HTML 32K
Information (Details)
29: R42 Discontinued Operations - Additional Information HTML 55K
(Details)
34: R43 Discontinued Operations - Net Earnings From HTML 37K
Discontinued Operations (Details)
37: R44 Discontinued Operations - Major Components of HTML 60K
Assets and Liabilities (Details)
44: R45 Discontinued Operations - Net Earnings From HTML 48K
Discontinued Operations for Beauty Brands
(Details)
26: R46 Discontinued Operations - Cash Flows for Beauty HTML 28K
Brands (Details)
32: R47 Discontinued Operations - Major Components of HTML 115K
Assets and Liabilities for Beauty Brands (Details)
24: R48 Discontinued Operations - Net Earnings From HTML 60K
Discontinued Operations for Batteries and Pet Care
(Details)
67: R49 Discontinued Operations - Major Components of HTML 72K
Assets and Liabilities for Batteries and Pet Care
(Details)
72: XML IDEA XML File -- Filing Summary XML 114K
25: EXCEL IDEA Workbook of Financial Reports XLSX 58K
17: EX-101.INS XBRL Instance -- pg-20150930 XML 1.77M
19: EX-101.CAL XBRL Calculations -- pg-20150930_cal XML 172K
20: EX-101.DEF XBRL Definitions -- pg-20150930_def XML 553K
21: EX-101.LAB XBRL Labels -- pg-20150930_lab XML 1.08M
22: EX-101.PRE XBRL Presentations -- pg-20150930_pre XML 722K
18: EX-101.SCH XBRL Schema -- pg-20150930 XSD 115K
30: ZIP XBRL Zipped Folder -- 0000080424-15-000098-xbrl Zip 165K
| Exhibit |
(1) | I have reviewed this quarterly report on Form 10-Q of The Procter & Gamble Company; |
(2) | Based on my knowledge, this report does not contain
any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
(3) | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
(4) | The
registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
a) | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries,
is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
b) | Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
c) | Evaluated the effectiveness of the
registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; |
d) | Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected,
or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and |
(5) | The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions): |
a) | All
significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and |
b) | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. |
/s/
A.G. LAFLEY |
Chairman of the Board, President and Chief Executive Officer |
Date |
| This ‘10-Q’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 10/23/15 | 8-K | ||
| For Period end: | 9/30/15 | 4 | ||
| List all Filings | ||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 8/05/22 Procter & Gamble Co. 10-K 6/30/22 109:15M 8/06/21 Procter & Gamble Co. 10-K 6/30/21 111:15M |